32 active trials 24 recruiting 7 Phase 3 16 disease areas 4 changes in 30 days
| Phase 1 | 11 | |
| Phase 1/2 | 5 | |
| Phase 2 | 9 | |
| Phase 3 | 7 |
| NCT ID | Title | Condition | Status | Updated |
|---|---|---|---|---|
| Phase 3 | ||||
| NCT07724366 | A Clinical Trial of TQH3906 Capsules in Adult Patients With Moderate to Severe Plaque… | Psoriasis | Recruiting | 2026-09-09 |
| NCT07047365 | TQB2930 Injection for the Treatment of HER2-positive Advanced Breast Cancer | HER2-positive Advanced Breast Cancer | Recruiting | 2026-06-03 |
| NCT07043725 | A Clinical Study of Neoadjuvant Treatment With TQB2102 for Injection for Human Epidermal… | HER2-positive Breast Cancer | Recruiting | 2026-03-27 |
| NCT07008976 | Clinical Trial of TQB2102 for Injection Versus Trastuzumab Emtansine for Injection in… | Metastatic Breast Cancer | Recruiting | 2025-08-14 |
| NCT07003074 | A Clinical Study of TQB2102 Versus Docetaxel Plus Trastuzumab and Pertuzumab in the… | Breast Cancer | Recruiting | 2025-06-25 |
| NCT06297655 | A Clinical Study of Recombinant Human Coagulation Factor VIII for Injection in Patients… | Hemophilia A | Active, Not Recruiting | 2026-06-12 |
| NCT07483684 | A Clinical Study to Evaluate Injection TQB2102 for the Treatment of Patients With HER2… | HER2 IHC3+ Advanced Colorectal Cancer | Not Yet Recruiting | 2026-03-19 |
| Phase 2 | ||||
| NCT07406035 | A Clinical Trial of TQH3906 Capsules in the Treatment of Active Psoriatic Arthritis | Psoriatic Arthritis | Recruiting | 2026-09-02 |
| NCT06496490 | A Clinical Trial of TQB2102 for Injection in Non-small Cell Lung Cancer With HER2 Gene… | Non-Small Cell Lung Cancer | Recruiting | 2025-11-20 |
| NCT06767813 | Clinical Study of TQB2868 Injection Combined With Anlotinib Capsule and Chemotherapy in… | Pancreatic Neoplasms | Recruiting | 2025-09-19 |
| NCT06767800 | A Clinical Trial Evaluating TQB2102 for Injection in Combination With… | Gastroesophageal Adenocarcinoma | Recruiting | 2025-07-30 |
| NCT06798207 | A Clinical Trial of TQB2102 for Injection in Gynecological Tumors With… | Gynecological Tumors | Recruiting | 2025-07-18 |
| NCT06962267 | A Clinical Study on the First-line Treatment of Metastatic Pancreatic Cancer With TQB2916… | Pancreatic Cancer | Recruiting | 2025-05-08 |
| NCT06452706 | The Clinical Trial of TQB2102 for Injection Against Human Epidermal Growth Factor… | Breast Cancer | Recruiting | 2024-11-19 |
| NCT06569524 | Efficacy and Safety of Recombinant Human FGF21-Fc Fusion Protein for Injection… | Non-alcoholic Steatohepatitis | Recruiting | 2024-08-26 |
| NCT06789289 | A Clinical Study to Evaluate the Efficacy and Safety of TQC2938 in Patients With Moderate… | Chronic Obstructive Pulmonary Disease | Active, Not Recruiting | 2026-04-07 |
| Phase 1/2 | ||||
| NCT07653685 | A Clinical Trial Evaluating TQB2930 Injection and Chemotherapy With or Without… | Colorectal Cancer | Recruiting | 2026-09-22 |
| NCT07512583 | Clinical Studies of TQB2930 Injection for the Treatment of Advanced Solid Tumors | Advanced Solid Tumor | Recruiting | 2026-06-08 |
| NCT06431490 | A Study of TQB2102 for Injection in the Treatment of HER2-positive Biliary Tract Cancer | Biliary Tract Cancer | Recruiting | 2026-04-08 |
| NCT06825494 | Clinical Studies for the Treatment of Advanced Solid Tumors | Advanced Solid Tumor | Recruiting | 2025-12-18 |
| NCT07044908 | TQB2922 and TAS-102 Tablets for Injection With or Without Bevacizumab in… | RAS/BRAF Wild Type Colorectal Cancer | Recruiting | 2025-08-12 |
| Phase 1 | ||||
| NCT06754891 | Clinical Trial of TQH3906 Capsules for the Treatment of Adult Patients With Moderately to… | Inflammatory Bowel Diseases | Recruiting | 2026-05-12 |
| NCT07043751 | A Clinical Trial Evaluating Injection of TQB6411 in Subjects With Advanced Malignant… | Advanced Malignant Tumors | Recruiting | 2026-01-21 |
| NCT07179679 | A Clinical Study Assessing the Subcutaneous Formulation of TQB2934 for Injection in… | Multiple Myeloma | Recruiting | 2025-12-11 |
| NCT07113925 | A Clinical Trial Evaluating TQB2101 in Subjects With Advanced Hematologic Malignancies | Advanced Hematologic Malignancies | Recruiting | 2025-08-11 |
Breast Cancer (6) · Colorectal Cancer (4) · Lung Cancer (3) · HER2-Positive Cancer (2) · Multiple Myeloma (2) · Non-Small Cell Lung Cancer (NSCLC) (2) · Pancreatic Cancer (2) · Psoriasis (2) · Cholangiocarcinoma (1) · Chronic Myeloid Leukemia (CML) (1)